Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
CD8+ T cells cross-restricted by HLA-B*57 and HLA-E*01 recognize HIV Gag with different functional profiles
Kevin J. Maroney, Michael A. Rose, Allisa K. Oman, Abha Chopra, Hua-Shiuan Hsieh, Zerufael Derza, Rachel Waterworth, Mark A. Brockman, Spyros A. Kalams, Anju Bansal, Paul A. Goepfert
Kevin J. Maroney, Michael A. Rose, Allisa K. Oman, Abha Chopra, Hua-Shiuan Hsieh, Zerufael Derza, Rachel Waterworth, Mark A. Brockman, Spyros A. Kalams, Anju Bansal, Paul A. Goepfert
View: Text | PDF
Research Article AIDS/HIV Infectious disease

CD8+ T cells cross-restricted by HLA-B*57 and HLA-E*01 recognize HIV Gag with different functional profiles

  • Text
  • PDF
Abstract

Few HIV-specific epitopes restricted by non-classical HLA-E have been described, and even less is known about the functional profile of responding CD8+ T cells (CD8s). This study evaluates the functional characteristics of CD8s targeting the Gag epitope KF11 (KAFSPEVIPMF) restricted by either HLA-E (E-CD8s) or HLA-B57 (B57-CD8s). CD8s from 8 people with HIV (PWH) were cocultured with KF11 peptide presented by cell lines expressing HLA-B*57:01, HLA-E*01:01, or HLA-E*01:03. CD8 responses were analyzed using single-cell RNA and TCR sequencing. Supernatants were also assessed for soluble protein profiling. HLA-I multimers were developed to identify CD8s restricted by HLA-B57 and/or HLA-E ex vivo. B57-CD8s secreted higher levels of cytotoxic cytokines such as IFN-γ, whereas E-CD8s produced more chemotactic cytokines, including RANTES, CXCL10 (IP-10), and IL-27, findings that were corroborated through single-cell RNA sequencing. TCR clonotypes stimulated by KF11 were cross-restricted by HLA-B*57 and HLA-E*01:03 as demonstrated by in vitro T cell reporter assays and ex vivo multimer screening. Ex vivo CD8s were singly restricted by HLA-B57 and HLA-E, with dual restriction only observed in PWH with lower viral load. These findings demonstrate that certain HIV-specific CD8s in PWH exhibit dual restriction by HLA-B*57 and HLA-E*01:03, leading to functionally distinct immune responses depending on the restricting allele(s).

Authors

Kevin J. Maroney, Michael A. Rose, Allisa K. Oman, Abha Chopra, Hua-Shiuan Hsieh, Zerufael Derza, Rachel Waterworth, Mark A. Brockman, Spyros A. Kalams, Anju Bansal, Paul A. Goepfert

×

Figure 2

Single-cell-sorted activated CD8 clonotypes are cross-restricted.

Options: View larger image (or click on image) Download as PowerPoint
Single-cell-sorted activated CD8 clonotypes are cross-restricted.
(A) Py...
(A) Pyramid plot representing total proportion of all TCR Vαβ family pairs observed in response to HLA-B*57:01–restricted (blue), HLA-E*01:01–restricted (red), and HLA-E*01:03–restricted (orange) KF11. Those pairs that were observed in 2 or 3 HLA restriction states are indicated as dual- or tri-restricted with an arrow and bracket. (B) Clusters of similar HLA-B*57:01–, -E*01:01–, and -E*01:03–restricted clonotypes are colored in blue, red, and orange, respectively. Clonotypes identified in non-controllers are represented as circles, while those in controllers and the ART-suppressed non-controller are represented as triangles and diamonds, respectively. Each cluster is labeled with the HLA-restricted state most common in the given cluster and colored accordingly. Additionally, every TRAV and TRBV family included in each is indicated for each cluster with font size scaled by prevalence. (C) The tri-restricted metaclonotype cluster containing the highest proportion of highly similar clonotypes from all 3 HLA restriction states is colored in green for all clonotypes that have TRAV5, while those that have a different α family are colored in black. (D) Line graph of fold change in functional affinity for TRAV5-containing complementarity-determining region 3 (CDR3) αβ pairs cloned into a Jurkat reporter cell line and co-incubated with HLA-B*57:01– or HLA-E*01:01–transduced HLA-null line pulsed with KF11. Fold change is for indicated HLA over HLA-A*02 cell line co-incubation pulsed with KF11. **P < 0.01 by Tukey’s multiple-comparison test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts